Archives: <span>Hypertriglyceridemia</span>

Study of Plozasiran in Adults With Hypertriglyceridemia (MUIR-3)

This Phase 3 study will evaluate the safety and efficacy of plozasiran injection in adult participants with hypertriglyceridemia (HTG). After providing informed consent eligible participants will be randomized to receive 4 doses (once every 3 months) of plozasiran or placebo and be evaluated for efficacy and safety.

Study of Plozasiran in Adults With Severe Hypertriglyceridemia (SHASTA-3)

Click the JOIN button if you think you might be eligible for this study. Company Please complete the form below with your contact information. By completing this form, you are providing your permission (consent) for research professionals to contact you about active or future studies and health research news. Email Address * First Name * Last Name